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and IGF-1. RV mRNA levels were linearly related (p<0.01) with those of the LV, both for
ACE (r=+0.88) and ET-1 (r=+0.71).
The present study showed that LV dysfunction in a model of selective RV overload is
accompanied by biventricular activation of regulatory (ACE and ET-1) systems, while
counter-regulatory BNP is selectively activated in the RV. These findings might add to the
understanding of the relative importance of load and autocrine/paracrine activation in the
progression to heart failure.
1029-184 The Clinical Significance of a Common, Functional, X-
Linked Angiotensin II Type 2-Receptor Gene 
Polymorphism (-1332 G/A) in a Cohort of 509 Families 
With Premature Coronary Artery Disease
Khaled Alfakih, Richard Lawrance, Azhar Maqbool, Kevin Walters, Stephen Ball, Anthony 
Balmforth, Alistair Hall, Leeds General Infirmary, Leeds, United Kingdom, University of 
Leeds, Leeds, United Kingdom
Background: A common intronic polymorphism, (-1332 G/A) of the angiotensin type 2
(AT2) receptor gene, located on the X-chromosome, has been reported to be biochemi-
cally functional.
Methods: We investigated 509 families from a cohort of families with a history of prema-
ture coronary artery disease (CAD). Families consisted of one sibling affected with pre-
mature CAD and two unaffected siblings. Genotyping of subjects was performed using a
restriction enzyme digestion of an initial 310 bp PCR fragment that included the AT2 (-
1332 G/A) locus.
Results: The mean age of the 611 siblings affected by premature CAD at the time of
event was 49.5 ± 8.1 yrs. Conditional logistic regression analysis confirmed a significant
predictive value of premature CAD for the covariates of hypertension, diabetes, dyslipi-
daemia, history of smoking, as well as male gender (p<0.005). The genetic data were
analysed using the XS-TDT statistics program which allows the calculation of exact p-val-
ues where the null hypothesis is of no linkage. In men (but not women) the G allele
occured significantly more frequently than would be expected if the disease causing
locus and AT2 (-1332 G/A) locus were unlinked; p-exact value = 0.024. The data were fur-
ther analysed to investigate linkage between this locus and a causative locus for hyper-
tension. In men we observed a trend towards linkage; p-exact value = 0.08.
Conclusion: We have found evidence of linkage between the AT2 (-1332 G/A) locus, and
a causative locus for premature CAD in men but not in women.
1029-185 Mobilization of Bone Marrow Cells With Granulocyte-
Colony Stimulating Factor Increases the CD34-Positive 
Mononuclear Cells in Peripheral Blood and Improves 
Angiogenesis, Ventricular Remodeling and Heart 
Function After Acute Myocardial Infarction in Rats
Hong Liu, Jianhui Shi, Naisheng Cai, Junbo Ge, Shanghai Institute of Cardiovascular 
Diseases, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China
Background: It’s reported that bone marrow endothelial progenitor cells (EPCs) can be
mobilized by myocardial infarction (MI). The aim of this study was to investigate the effect
of granulocyte-colony stimulating factor (G-CSF) in mobilizing the putative precursor of
EPCs [CD34-positive monoculear cells (MNCsCD34+)] from bone marrow and the correla-
tion to heart function in a rat MI model. Methods: G-CSF (n=8, 150 µg/kg/day) or pla-
cebo (n=8) were given subcutaneously to left coronary artery-ligated rats for 5 days after
operation. On the 6th post-operation day, MNCs were seperated and labeled with anti-
CD34 for FACS analysis. Echocardiography was performed for assessment of heart func-
tion before rats were killed at 6 weeks after operation. Results: 1) Leucocytes and MNCs
in peripheral blood in CSF-treated group were increased by 2-fold (25.17±10.93/ml vs.
10.14±3.09/ml* and 20.55±10.42/ml vs. 9.12±2.86/ml*, *p<0.05 vs. G-CSF group), neu-
trophil by 4-fold (4.61±2.95/ml vs. 1.02±0.6/ml*), MNCsCD34+ by 6-fold (262.79±73.63/µl
vs. 43.9±29.77/µl*) compared to the control group 6 days after MI. Erythroctyes and
thrombocytes were similar between the two groups. 2) The capillary density of the CSF-
group in scar and border zone was increased significantly. 3) LVDD (left ventricular end-
diastolic diameter, 0.83±0.09 cm vs. 0.70±0.08 cm*) was attenuated, scar thickness
increased (0.13±0.02 cm vs. 0.17±0.02 cm*) and LVEF increased (88.89±4.14% vs.
66.22±13.35%*) by G-CSF compared to the control group 6 weeks after MI; 4) The num-
ber of circulating MNCsCD34+ was positively correlated with LVEF (r=0.84, p<0.05). Con-
clustions: Mobilization of bone marrow cells with G-CSF increases the CD34-positive
mononuclear cells in peripheral blood and improves angiogenesis, ventricular remodeling
and heart function after acute myocardial infarction in rats.
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1045-189 Plaque Targeting in Atherosclerotic Mice Using a Small 
ImmunoProtein Against an Angiogenesis-Associated 
Fibronectin Isoform
Pia K. Schuler, Christian M. Matter, Patricia Meier, Romeo Ricci, Dongming Zhang, 
Patrizia Alessi, Dario Neri, Thomas F. Lüscher, University of Zurich, Zurich, Switzerland, 
Federal Institue of Technology, Zurich, Switzerland
Background: Currently, human atherosclerotic plaques can be visualized by angiography,
ultrasound, CT and MRI. However, these imaging modalities are restricted to detect
advanced atherosclerotic lesions. The aim of our study was to visualize early atheroscle-
rotic plaques at the molecular level using an antibody against the extra-domain B of
fibronectin (L19).
Methods: L19 was marked with radioactivity (I-125) or fluorescence (Cy5) and injected
intravenously in apolipoprotein E knockout (ApoE ko) and corresponding control mice.
24h after injection of the tagged L19, the aorta was isolated for en face and cross sec-
tional analysis. An unspecific antibody was used as a control for L19.
Results: Plaques could be clearly visualized in all ApoE ko mice after injection of labeled
L19 (Fig.A). Specifically, the signal after phosphorimaging of the en face aorta following
injection with radiolabeled L19 exactly matched the fat staining of plaques using Oil Red
O (Fig.B). Similarly, fluorescent staining with Cy5 corresponded with plaques on cross
sections. No signal was observed in normal vessels and in ApoE ko mice injected with
the unspecific antibody.
Conclusions: L19 enabled us to specifically identify atherosclerotic plaques and thus,
may provide a novel molecular tool for plaque diagnosis. Furthermore, these findings
may set the stage for a non-invasive plaque therapy by coupling anti-atherogenic drugs to
the proposed antibody.
1045-190 Documentation of Exercise-Induced Coronary Collateral 
Growth in Humans
Rainer Zbinden, Stefan Zbinden, Kerstin Wustmann, Michael Billinger, Jean-Paul 
Schmid, Stefan Windecker, Bernhard Meier, Christian Seiler, Cardiovascular Center 
Bern, Bern, Switzerland
Background: Collateral vessels can reduce the often fatal consequences of a sudden cor-
onary artery occlusion. Collateral arteries develop out of preexesting arteriolar anasto-
moses in response to increased shear forces. We hypothesized that a long-term exercise
program (increasing vascular shear forces) leads to:
1)Increased collateral flow as obtained in an angiographically normal coronary artery
2)Lack of decrease in collateral flow expected after percutaneous coronary intervention
(PCI) in a diseased coronary artery
3) A dose-response relation between the degree of fitness following training and change
in coronary collateral flow.
Methods: Thirty-four patients (age 61 ± 8 years) undergoing PCI because of stable
angina pectoris were included in the study. They performed a 3-months physical endur-
ance exercise program (3 times per week, 1 hour per session) with baseline and follow-
up invasive collateral flow index measurements (CFI, no unit). CFI was measured using a
sensor-tipped PCI guidewire distal to the balloon-occluded coronary artery in a vessel
without stenosis and in a diseased coronary artery undergoing ad-hoc PCI. Spiroergom-
etry was performed at baseline and follow-up.
Results: There was a significant increase in CFI in the angiograpically normal vessel
(baseline: 0.19 ± 0.09; follow-up: 0.23 ± 0.08; p=0.003) and the expected decrease in
CFI in the vessel undergoing PCI was prevented (baseline: 0.18 ± 0.09; follow-up: 0.20 ±
0.06; p=NS). There was a direct dose-response relation between delta VO2max and
change of CFI in the normal vessel (p=0.04;r= 0.42).
Conclusion: Endurance exercise training induces the growth of collateral arteries (“arteri-
ogenesis”) in a myocardial region supplied by an angiographically normal vessel and it
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prevents the expected reduction in collateral flow after PCI of a stenotic vessel. There is a
direct dose-response relation between exercise capacity gained and coronary collateral
flow augmentation in the angiographically normal vessel.
1045-191 High-Density Lipoprotein-Induced Tube Formation 
Requires the Activation of Ras/Raf/Mitogen-Activated 
Protein Kinase in Human Coronary Artery Endothelial 
Cells
Shin-ichiro Miura, Masahiro Fujino, Hiroyuki Tanigawa, Yoshino Matsuo, Akira 
Kawamura, Hiroaki Nishikawa, Keijiro Saku, Fukuoka University School of Medicine, 
Fukuoka, Japan
Objectives: High density lipoprotein (HDL) levels have been shown to be inversely corre-
lated with coronary artery disease, but the mechanisms of the direct protective effect of
HDL on endothelial cells (ECs) are not fully understood. In this study, we investigated the
role of the HDL–mediated promotion of angiogenesis in human coronary artery ECs
(HCECs).
Methods and Results: We developed an in vitro model of HCEC tube formation on a
matrix gel. HDL induced tube formation, in which the dose-response showed that the
maximum effective dose of HDL was 100 µg/ml. We also examined the effect of sphin-
gosine-1-phosphate (S1P), which is a carrier of bioactive lipids of HDL, to analyze tube
formation. Since HDL contains S1P (about 180 pmol/mg protein), 100 µg/ml of HDL con-
tains about 0.018 µM of S1P. Although we observed 0.02 µM of S1P significantly induced
tube formation, it was only 20 % of 100 µg/ml HDL-induced tube formation. HDL-induced
tube formation may be partly mediated by S1P. PD98059, an inhibitor of p42/44 mitogen-
activated protein kinase (MAPK) activity, but not SB203580, an inhibitor of p38 MAPK
activity, suppressed HDL-induced tube formation. Dominant-negative Ras N17 inhibited
HDL-induced tube formation. HDL activated Ras by ras pull-down assay and its effect
was inhibited by pertusis toxin (PTX). Moreover, HDL activated phospho(p)-p42/44
MAPK, while Ras N17 blocked HDL-induced pp42/44 MAPK.
Conclusions: These results indicate that HDL induced a potent signal through a Ras/
MAPK pathway mediated by PTX-sensitive G-protein coupled receptor to the angiogenic
phenotype in HCECs.
1045-192 Monocytes, but Not Neutrophils or Lymphocytes Are 
Essential Mediators of Arteriogenesis
Sebastian Grundmann, Imo Hoefer, Niels van Royen, Stephan Schirmer, Susann 
Ulusans, Ivo Buschmann, University Hospital, Freiburg, Germany, Perfusion 
Technologies, Freiburg, Germany
Background: Blood vessel growth following arterial occlusion is mediated by infiltrating
leukocytes. While all three leukocyte subpopulations (neutrophils, lymphocytes, mono-
cytes) are known to play an important role in angiogenesis, only monocytes have been
shown to influence the growth of collateral arteries (arteriogenesis). In this study we
examined the importance of neutrophils and lymphocytes in a rabbit hindlimb model of
arteriogenesis. Methods: 36 Rabbits received either Interleukin-8 (IL-8), Neutrophil-acti-
vating-protein-2 (NAP-2) or Lymphotactin (Ltn) via osmotic minipumps directly into the
collateral circulation after femoral artery ligation. NAP-2 is a relatively selective activator
of neutrophils, Ltn chemoattracts lymphocytes and Il-8 has an effect on both celltypes.
PBS and MCP-1 treated groups served as controls. After one week, leukocytes around
growing collateral arteries were quantified via immunohistology and effects on integrin
markers of leukocytes activation (Mac-1, LFA-1) were assessed by flow-cytometry. Col-
lateral conductance was assessed using fluorescent microspheres. Results: Although a
significant increase in neutrophil accumulation after IL-8 and NAP-2 treatment was
detected in-vivo (cells/mm2: PBS:8,33±2,87,MCP-1:25,23±10,81,IL-8:36,06±12,65,NAP-
2:20,67±7,41,Ltn:8,27±5,44) and Il-8 and NAP-2 resulted in neutrophil activation in flow-
cytometry (Mac-1 Expression: PBS:21,12±2,11,MCP-1:24,11±2,64,IL-
8:32,65±2,10,NAP-2:27,30±2,25, Ltn:17,30±2,16), no significant increase in collateral
conductance was observed. Ltn treatment resulted in lymphocyte accumulation (cells/
mm2: PBS:2,48±1,24,MCP-1:4,26±1,16,IL-8:6,88±5,28,NAP-
2:2,70±0,57,Ltn:12,80±3,50), but not in collateral artery growth. Collateral conductance:
[ml/min/100mmHg]: PBS:50,70±5,15, MCP-1:339,60±19,6, IL-8:58,91±5,56, NAP-
2:66,83±8,72, Ltn:52,80±5,37. Conclusion: While lymphocytes and neutrophils are
known to participate in angiogenesis, their importance for arteriogenesis seems to be
neglectible. These findings support the hypothesis of monocytes/macrophages as key
mediators of collateral artery growth.
1045-193 Granulocyte-Colony Stimulating Factor Mobilizes and 
Activates Endothelial Progenitor Cells in Patients With 
Coronary Artery Disease
Tiffany M. Powell, Jonathan D. Paul, Jonathan M. Hill, Elizabeth J. Read, Philip J. McCoy, 
Richard O. Cannon, III, National Institutes of Health, Bethesda, MD
Background: Circulating endothelial progenitor cells may function to repair cardiovascu-
lar injury, but are reduced in patients with coronary artery disease. Granulocyte-colony
stimulating factor (G-CSF) mobilizes hematopoietic stem cells (CD34+) in healthy sub-
jects, but whether this cytokine mobilizes endothelial progenitor cells capable of endothe-
lial maturation in coronary artery disease patients is unknown. Methods: G-CSF (10
mcg/kg) was administered daily for 5 days to 12 coronary artery disease patients, and
circulating CD34+ cells, endothelial progenitor cells (CD133/ VEGFR-2+), and mature
endothelial cells [CD144 (VE-cadherin), CD31 (PECAM), CD51/61 (alphavbetaIII inte-
grin)] were measured by flow cytometry. Results: G-CSF increased CD34+ cells from <1
cell/microL of blood at baseline to 60±18 cells/microL within 24 hours of the last dose
(p<0.001), similar to CD34+ mobilization achieved in 28 healthy donors >40 years of age
at our hospital (78±8 cells/microL). Endothelial progenitor cells were also mobilized,
although to low levels (from <1 cell/microL at baseline to 6±3 cells/microL within 24 hours
of last G-CSF dose, p<0.001). Mature circulating endothelial cells also increased post-G-
CSF: CD34/CD144+ from 16±16 to 107±90 cells/microL, CD34/CD31+ from 54±28 to
224±60 cells/microL, CD34/CD51/61 from 14±14 to 81±64 cells/microL (all p<0.05 vs
baseline). One week following completion of treatment, CD34+ cells and endothelial pro-
genitor cells had returned to baseline, but levels of mature endothelial cells remained
increased over baseline (p<0.05). Conclusion: These findings establish that G-CSF
administration to coronary artery disease patients mobilizes CD34+ cells, which includes
the endothelial progenitor cell subset, into the circulation. Mobilization is associated with
increased cells expressing mature endothelial markers, which persist even at one week
following the last dose of G-CSF. This suggests sustained G-CSF-stimulated differentia-
tion along an endothelial cell lineage, with potential therapeutic implications for neovas-
cularization of ischemic myocardium.
1045-194 Impaired Arteriogenic Response to Acute Hindlimb 
Ischemia in CD8 Knockout Mice
Eugenio Stabile, Mary Susan Burnett, Timothy D. Kinnaird, Craig Watkins, Cheol W. Lee, 
Matie Shou, Andrea la Sala, Schmuel Fuchs, Stephen E. Epstein, Washington Hospital 
Center, Washington, DC
Background: CD8+ cytotoxic T lymphocytes regulate cellular responses of the immune
system, which play a pivotal role in modulating collateral vessel development.
The aim of our study was to investigate if the absence of circulating CD8+ T-cells impairs
collateral development after femoral artery ligation in CD8 -/- mice.
Methods and Results: After surgical excision of the femoral artery, Laser Doppler Perfu-
sion Imaging demonstrated reduced collateral flow induction in CD8 -/- mice compared to
control mice (C57BL/6J) at day 3 (0.21±0.01 vs 0.29±0.03, p< 0.01) which persisted to
day 28 (0.69±0.04 vs 0.90±0.04, p< 0.01). In CD8 -/- mice , when compared to controls,
the biological importance of the reduced collateral flow was evident by diminished recov-
ery of hindlimb function (ambulatory impairment score: 1.73 ± 0.18 vs 0.86 ± 0.19, p<
0.01), greater calf muscle atrophy (mean fiber area 767 ± 68 vs 1067 ± 69, µm2, p<
0.01), and increased fibrotic tissue content (14 ± 1% vs 7 ± 1%, p< 0.01). Exogenous
CD8+ T-cells, when infused into CD8-/- mice immediately after ischemia induction, selec-
tively home at the site of collateral formation and, over time, significantly increased collat-
eral flow, improved hindlimb functional recovery, and reduced muscle atrophy/fibrosis.
Conclusions: These results demonstrate that CD8+ T-cells are a critical component of
the immune system in regulating the early phase of normal collateral development. CD8 -
/- mice demonstrated both delayed and impaired blood flow recovery after femoral artery
ligation, and infusion of CD8+ T cells immediately after surgery rescued the phenotype.
Our study provides further evidence that the immune system is critical in modulating col-
lateral development in response to peripheral ischemia.
1045-195 Monocyte Chemoattractant Protein-1 Activates Vascular 
Endothelial Growth Factor- and Tumor Necrosis Factor-
Alpha-Mediated Angiogenesis in Ischemic Hindlimbs of 
Mice
Hiroshi Niiyama, Hisashi Kai, Hironobu Tahara, Toyoaki Murohara, Tsutomu Imaizumi, 
Kurume Univeristy, Kurume, Japan
Recently, we and others have suggested that macrophage accumulation plays a role in
angiogenesis in hindlimb ischemia model. Macrophage chemoattractant protein (MCP)-1
is a key molecule to trigger inflammatory changes in various diseases. Thus, we sought
to determine the role of the endogenous MCP-1 in ischemia-induced angiogenesis. At
day 0, unilateral hindlimb ischemia was induced by excising surgically entire left femoral
artery and vein in mice. Immediately after operation, plasmid DNA encoding 7ND, a dom-
inant negative mutant of MCP-1, or the empty plasmid (as control) was injected into the
ipsilateral thigh adductor muscle. Serial laser Doppler blood flow analysis showed an
abrupt decrease in blood flow, followed by a remarkable recovery, in ischemic hindlimbs
of controls. Control mice showed well-developed collateral vessels and capillary forma-
tion as assessed by postmortem angiography and immunohistostaining for CD31,
respectively, at day 21 after induction of ischemia. In 7ND-treated mice, although the
extent of the early decrease in laser Doppler blood flow was similar to that in controls, the
recovery was impaired. At day 3, macrophage infiltration and inductions of vascular
endothelial growth factor (VEGF) and tumor necrosis factor (TNF)-alpha, known angio-
genic factors, were prominent in the adductor muscle of ischemic hindlimbs in controls.
7ND treatment significantly reduced the number of infiltrated macrophages and
repressed VEGF and TNF-alpha inductions in response to ischemia at day 3. Moreover,
the number of angiographically visible collateral vessels and the capillary density were
significantly decreased in ischemic hindlimbs of 7ND-treated mice at day 21. In conclu-
sion, MCP-1-mediated macrophage accumulation may play an important role in
ischemia-induced angiogenesis at least in part by activating induction of angiogenic fac-
tors such as VEGF and TNF-alpha in ischemic hindlimbs.
1045-196 Fiber Type-Specific Angiogenic Dysregulation in a 
Genetic Mouse Model of Heart Failure
Richard E. Waters, II, Brian Annex, Zhen Yan, Duke University Medical Center, Durham, 
NC
Introduction. Chronic heart failure (CHF) leads to intrinsic skeletal muscle abnormalities
including slow-oxidative to fast-glycolytic fiber type switching, decreased capillary den-
sity, and reduced mitochondrial function. These skeletal muscle abnormalities contribute
to clinical exercise intolerance. Methods. A genetic mouse model of heart failure induced
through cardiac-targeted overexpression of the sarcoplasmic reticulum Ca2+ storage pro-
tein calsequestrin (CSQ) has been recently characterized. Skeletal muscle (plantaris)
from CSQ/CHF mice and wild type (WT) mice was analyzed with triple color immunof-
lourescence using antibodies specific for myosin heavy chain I, IIa, IIb, and endothelial
cells. Results. A decrease in oxidative myofibers (I + IIa), a concurrent increase in glyco-
